Back to overview

CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway

Type of publication Peer-reviewed
Publikationsform Original article (peer-reviewed)
Author Graule Janina, Uth Kristin, Fischer Elia, Centeno Irene, Galván José A., Eichmann Micha, Rau Tilman T., Langer Rupert, Dawson Heather, Nitsche Ulrich, Traeger Peter, Berger Martin D., Schnüriger Beat, Hädrich Marion, Studer Peter, Inderbitzin Daniel, Lugli Alessandro, Tschan Mario P., Zlobec Inti,
Project Analyzing and modulating the epigenetic landscape of CDX2 as well as studying its function in colorectal cancer pathology
Show all

Original article (peer-reviewed)

Journal Clinical Epigenetics
Volume (Issue) 10(1)
Page(s) 120 - 120
Title of proceedings Clinical Epigenetics
DOI 10.1186/s13148-018-0548-2

Open Access

Type of Open Access Publisher (Gold Open Access)